Atrial fibrillation is the most common arrhythmia, affecting an estimated 2.3 million patients in North America.1 It is associated with a risk of stroke about 5 times higher than that of patients with sinus rhythm.2 Therapy for prevention of cardioembolic stroke is a cornerstone of AF management.
Moss JD, Cifu AS. Management of Anticoagulation in Patients With Atrial Fibrillation. JAMA. 2015;314(3):291–292. doi:10.1001/jama.2015.3088
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: